Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Authors:: Amjad Khan; Somia Iqtadar; Sami Ullah Mumtaz; Michael Heinrich; Domingo A. Pascual-Figal; Shona Livingstone; Sajid Abaidullah

Reference:: Frontiers in Pharmacology; 2022; 13; 898062

DOI:: 10.3389/fphar.2022.898062

See Abstract

Key Words:: Clinical study; randomization; controlled study; open-label; parallel-group; COVID-19; curcumin; quercetin; vitamin D3; speedy negativization; C reactive protein

Back to index